Piñón-García K, Rosales-Torres P, Toledo-Cabarcos Y, Correa-Borrell M

Language: Spanish
References: 12
Page:
PDF size: 580.48 Kb.

ABSTRACT

Introduction: The malignant mixed müllerian tumor is an infrequent, aggressive uterine neoplasm and is histologically characterized by containing sarcomatous and carcinomatous malignant elements.
Objective: To describe a case of a malignant mixed Müllerian tumor and to review the literature on the subject.
Case report: A 63-year-old black female patient, obese and hypertensive under treatment, with a history of right mastectomy six months ago, who was consulted due to increased abdominal volume, lower abdominal pain and uterine bleeding. With the administration of combined anesthesia (general orotracheal and continuous epidural regional) a giant uterine fibroid was resected and the diagnosis of a malignant mixed Müllerian tumor was confirmed.
Conclusions: Malignant mixed Müllerian tumor should be suspected in elderly women with genital bleeding accompanied by a pelvic mass. The pathological study is of choice for the definitive diagnosis of this rare and potentially aggressive neoplasm. Surgery, radiotherapy and chemotherapy are the most accepted therapeutic options, however, in women with advanced stage tumors, regardless of the treatment provided, the survival rate is short.

REFERENCES

1. An Y, Wang Q, Sun F, Zhang G, Wang F, Zhang L, et al. OSucs: An Online Prognostic Biomarker Analysis Tool for Uterine Carcinosarcoma. Rev Genes [Internet]. 2020 [citado 11 Dic 2020];11(9):[aprox. 13 p.]. Disponible en: Disponible en: https://www.mdpi.com/2073-4425/11/9/1040 1.

2. Bhattarai A, Pariyar J, Neupane S, Koirala S, Pokhrel P, Sapkota S, et al. Carcinosarcoma of the Uterus: An Elusive Diagnosis. Rev Nepalese Journal of Cancer [Internet]. 2020 [citado 11 Dic 2020];4(1):24-27. Disponible en: Disponible en: http://nepmed.nhrc.gov.np/index.php/NJC/article/download/889/702 2.

3. Vordermark D, Medenwald D, Izaguirre V, Sieker F, Marnitz S. The Role of Postoperative Radiotherapy for Carcinosarcoma of the Uterus. Rev Cancers [Internet]. 2020 [citado 11 Dic 2020];12(12):[aprox. 10 p.]. Disponible en: Disponible en: https://www.mdpi.com/2072-6694/12/12/3573 3.

4. Biscuola M. Caracterización molecular de los carcinosarcomas de endometrio [Tesis]. Sevilla: Universidad de Sevilla; 2018 [citado 11 Dic 2020]. Disponible en: Disponible en: https://idus.us.es/handle/11441/81606 4.

5. Ravishankar P, Smith DA, Avril S, Kikano E, Ramaiya NH. Uterinecarcinosarcoma: a primer for radiologists. Rev Abdominal Radiology [Internet]. 2019 [citado 11 Dic 2020];44(8):2874-2885. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31030248/ 5.

6. Kord A, Rabiee B, Elbaz Younes I, Xie KL. Uterine Carcinosarcoma: A Case Report and Literature Review. Rev Case Rep Obstet Gynecol [Internet]. 2020 [citado 11 Dic 2020];2020:[aprox. 6 p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455848/ 6.

7. Bassetto CC, Martins GL, Lombardi W. Carcinossarcoma de colo uterino-A dificuldadeem se estabelecer o diagnóstico. Rev Relatos Casos Cir [Internet]. 2020 [citado 11 Dic 2020];6(1):[aprox. 5 p.]. Disponible en: Disponible en: https://cdn.publisher.gn1.link/relatosdocbc.org.br/pdf/v6n1a09.pdf 7.

8. Cuevas IC, Sahoo SS, Kumar A, Zhang H, Westcott J, Aguilar M. Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition. Rev PNAS [Internet]. 2019 [citado 11 Dic 2020];116(51):25880-90. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31772025/ 8.

9. Giuliani A, Romano L, Romanzi F, Giubbolini G, Coletti G, Di Stefano N, et al. A case of three rareuterineneoplasms in the same surgical specimen. Rev Ann Ital Chir [Internet]. 2020 [citado 11 Dic 2020];9:[aprox. 6 p.]. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32129176/9.

10. Dwivedi SKD, Rao G, Dey A, Buechel M, Zhang Y, Zhang M. Targeting the TGFβ pathway in uterine carcinosarcoma. Rev Cell Stress [Internet]. 2020 [citado 11 Dic 2020];4(11):252-60. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590842/ 10.

11. Reis-de-Carvalho C, Borges A, Djokovic D. A Rare and Aggressive Uterine Cancer: Carcinosarcoma. Rev J Radiol Clin Imaging[Internet]. 2020 [citado 11 Dic 2020];3(2):056-057. Disponible en: Disponible en: https://www.fortunejournals.com/articles/a-rare-and-aggressive-uterine-cancer-carcinosarcoma.html 11.

12. Alvarado-Cabrero I, Estevez-Castro R, Valencia-Cedillo R. Estado actual del carcinoma de endometrio. Rev Patología Latinoam [Internet]. 2020 [citado 11 Dic 2020];58:1-9. Disponible en: Disponible en: https://www.researchgate.net/profile/Rafael_Estevez-Castro/publication/340471748_Estado_actual_del_carcinoma_de_endometrio_Current_status_of_endometrial_carcinoma/links/5e8be2274585150839c6397f/Estado-actual-del-carcinoma-de-endometrio-Current-status-of-endometrial-carcinoma.pdf 12.